Danese, S., Klopocka, M., Scherl, E. J., Romatowski, J., Allegretti, J. R., Peeva, E., Vincent, M. S., Schoenbeck, U., Xi, L., Ye, Z., Hassan-Zahraee, M., Rath, N., Li, G., Neelakantan, S., Banfield, C., Lepsy, C., Chandra, D., & Hung, K. E. (n.d.). dOP72 Safety, tolerability and efficacy of anti-TL1A antibody PF-06480605 in treatment of ulcerative colitis: The open-label, multicentre, Phase 2a TUSCANY study. Journal of Crohn's and colitis, 14, S108–S110. http://access.bl.uk/ark:/81055/vdc_100099171458.0x000034